BCM
TECH icon

Bayesian Capital Management’s Bio-Techne TECH Stock Holding History

Bayesian Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-23,617
Closed -$1.22M – 794
2025
Q2 		$1.22M Buy
23,617
+18,902
+401% +$950K 0.19% 156
2025
Q1 		$276K Sell
4,715
-6,685
-59% -$453K 0.05% 408
2024
Q4 		$821K Buy
+11,400
New +$837K 0.1% 274
2024
Q2 		– Sell
-13,693
Closed -$964K – 1086
2024
Q1 		$964K Buy
+13,693
New +$980K 0.09% 290
2023
Q2 		– Sell
-4,800
Closed -$356K – 1059
2023
Q1 		$356K Buy
+4,800
New +$370K 0.04% 471
2021
Q3 		– Sell
-2,956
Closed -$333K – 540
2021
Q2 		$333K Buy
2,956
+156
+6% +$16.4K 0.09% 250
2021
Q1 		$267K Buy
+2,800
New +$255K 0.06% 378
2016
Q2 		– Sell
-17,600
Closed -$416K – 545
2016
Q1 		$416K Buy
+17,600
New +$388K 0.39% 75

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Bayesian Capital Management's TECH Position: Q3 2025 in Review

Bayesian Capital Management sold out of Bio-Techne (TECH) in Q3 2025, closing a stake of 23,617 shares — an estimated $1.22M sold.

Bayesian Capital Management first reported a position in TECH in Q1 2016 and held it in 8 quarters. The position peaked at $1.22M in Q2 2025. 577 funds tracked by Wall St. Rank hold TECH as of Q3 2025.

  • Bayesian Capital Management reported no remaining Bio-Techne position as of Q3 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 23,617 Bio-Techne shares in Q3 2025, an estimated $1.22M.
  • Bayesian Capital Management first reported a position in Bio-Techne in Q1 2016 and held it in 8 quarters.
  • Bayesian Capital Management's Bio-Techne position peaked at $1.22M in Q2 2025.
  • 577 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2025.

Based on Bayesian Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.